These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26010505)

  • 21. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V; Piraccini BM
    Clin Drug Investig; 2019 Mar; 39(3):233-239. PubMed ID: 30652260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia.
    Iwabuchi T; Takeda S; Yamanishi H; Ideta R; Ehama R; Tsuruda A; Shibata H; Ito T; Komatsu N; Terai K; Oka S
    J Cosmet Dermatol; 2016 Jun; 15(2):176-84. PubMed ID: 27030543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid.
    Abadjieva TI
    Folia Med (Plovdiv); 2000; 42(3):26-9. PubMed ID: 11347332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red ginseng in treating female pattern alopecia.
    Ryu HJ; Yoo MG; Son SW
    Int J Dermatol; 2014 Jun; 53(6):e340-2. PubMed ID: 24451023
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
    Price VH; Menefee E; Strauss PC
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells.
    Scaglione F; Lucini V; Pannacci M; Caronno A; Leone C
    Pharmacology; 2008; 82(4):270-5. PubMed ID: 18849646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
    Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
    Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Cuscuta reflexa Roxb on androgen-induced alopecia.
    Pandit S; Chauhan NS; Dixit VK
    J Cosmet Dermatol; 2008 Sep; 7(3):199-204. PubMed ID: 18789055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
    Mantovani F
    Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.